New York Recreational & Medical Marijuana Licensing Guide

Adult Use

In New York, the adult use of marijuana was legalized on March 31, 2021, with the passing of the Marijuana Regulation and Taxation Act (MRTA). This act established the Cannabis Control Board and the Office of Cannabis Management (OCM) as the primary regulatory bodies responsible for overseeing the licensing, production, sale, and use of marijuana in the state.

Types of Licenses and Acquisition Process

New York has established several types of licenses for the marijuana industry, each tailored to different aspects of the marijuana supply and sales chain:

  • Cultivator License – This license allows for the growing of cannabis. The application process requires prospective growers to demonstrate compliance with state regulations, including security measures and environmental sustainability practices. Fees vary depending on the scale of the operation.
  • Processor License – This license is required for businesses intending to manufacture marijuana products, such as edibles or concentrates. Applicants must provide detailed operational plans and pass stringent safety inspections.
  • Distributor License – Distributors are responsible for transporting cannabis products between facilities, such as from cultivation sites to dispensaries. Applicants need to show they can comply with transportation and security regulations.
  • Retail Dispensary License – Retailers can sell marijuana directly to consumers. This license requires applicants to meet specific location criteria to avoid proximity to schools or community centers, and they must also ensure that their operations are accessible and secure.
  • Delivery License – This permits the delivery of cannabis directly to consumers from dispensaries. Like other licenses, it requires adherence to security protocols and includes restrictions on delivery areas and times.
  • On-Site Consumption License – This unique license allows for the consumption of cannabis products at specific locations, similar to bars for alcohol. These sites are subject to location restrictions and health and safety standards.

 

Application Process and Costs

The application process for each type of license includes background checks, detailed business and operational plans, and compliance with environmental and security regulations. Costs for licenses vary, with different fees for application, licensing, and potential operational fees depending on the type and scale of the business.

Restrictions and Regulations

New York’s cannabis laws include specific restrictions aimed at minimizing the impact of cannabis businesses on their communities. These include zoning laws that regulate the distance of cannabis businesses from schools and community centers, stringent product testing requirements to ensure consumer safety, and caps on the number of licenses to prevent market oversaturation. Additionally, the state has provisions to encourage participation in the cannabis industry from previously marginalized or economically disadvantaged communities. This includes prioritizing license applications from individuals in communities disproportionately impacted by previous drug enforcement policies.

Regulatory Oversight

The OCM monitors compliance and enforces regulations across all types of cannabis licenses. It ensures that all operators in the market adhere to the state’s standards for safety, quality, and accessibility.

This framework sets the stage for a regulated market intended to ensure public safety, reduce illegal sales, generate significant tax revenue, and rectify past injustices caused by the enforcement of previous marijuana laws in New York.

Hemp

On March 31, 2021, New York State legalized adult-use cannabis by passing the Marijuana Regulation and Taxation Act (MRTA). The legislation created The Office of Cannabis Management (OCM) governed by a Cannabis Control Board (CCB) to oversee and implement the law. However, the OCM now also oversees the state’s existing Cannabinoid Hemp Program. The Cannabinoid Hemp Program was created pursuant to Chapter 1 of the Laws of 2020 to implement basic consumer protections and ensure cannabinoid hemp products sold in New York State are properly manufactured, laboratory tested, and accurately labeled. Individuals who are processing, manufacturing, or selling cannabinoid hemp products in New York State are required to hold a license or permit to do so. 

New York State’s Department of Agriculture and Markets oversees hemp cultivation and hemp used exclusively for industrial or food purposes. Meanwhile, as mentioned, the OCM regulates hemp used or marketed for its cannabinoid content, such as cannabidiol (CBD). The following forms are permitted for retail sale: tinctures, oils, topicals, pills, capsules, supplements, and food or beverages containing cannabinoids that are intended for human consumption or application. THC concentrations less than or equivalent to 0.3 percent are permitted in products sold under the New York State Cannabinoid Hemp Program. New York State requires anyone who is processing, manufacturing, or selling cannabinoid hemp to first obtain a license from the Cannabinoid Hemp Program. The OCM has approved regulations to implement the Cannabinoid Hemp Program; and these regulations establish standards for manufacturing, laboratory testing, and packaging and labeling. 

Currently, the OCM is accepting applications and issuing licenses for Cannabinoid Hemp Retailers, Processors, and Distributors.

Psychedelics

In New York, psychedelic substances are classified under state scheduling, which reflects their legal status and controls under the law. Efforts to change the status of psychedelics have been pursued, primarily focusing on substances like psilocybin due to their potential therapeutic benefits.

 

  • Ketamine and Telehealth Laws – Ketamine, legally used as an anesthetic, has been accessible under New York’s telehealth laws which permit controlled substances to be prescribed via telemedicine under specific guidelines. This development has expanded access to ketamine-assisted therapy for conditions such as depression, especially significant in the era of COVID-19, which saw an expansion of telehealth practices.
  • State Right to Try – New York has explored the “Right to Try” approach, which allows terminally ill patients to access investigational drugs that have completed the first phase of clinical trials but have not been approved by the FDA. This could potentially include psychedelic substances if they meet the criteria.
  • State Religious Exemptions – Religious exemptions for the use of psychedelics in New York are not explicitly defined in state law. However, federal rulings, such as the U.S. Supreme Court’s decision in Gonzales v. O Centro Espirita Beneficente Uniao do Vegetal, have recognized some religious uses of psychedelics under the Religious Freedom Restoration Act, providing a degree of protection that could influence state policies.

Recent legislative actions include proposals to reduce penalties and expand medical use of psychedelics:

  • Bill A8569 (2021) by Assemblymember Pat Burke proposed establishing psilocybin service centers.
  • Bill A7928 (2021) by Assemblymember Linda B. Rosenthal aimed to create a public psychedelic research institute.
  • Bill A6065 (2021 & 2022), also by Rosenthal, sought to decriminalize psilocybin and other natural psychedelics, emphasizing adult use and the provision of supportive services.
  • A00114 (2023) introduced by Assemblymember Rosenthal, aimed to legalize certain natural psychedelics for adult use and establish protections for users.
  • S3520 (2023) by Senator Nathalia Fernandez proposed a psilocybin-assisted therapy grant program for medical use, specifically targeting veterans and first responders.

These bills reflect a growing interest in integrating psychedelics into therapeutic practices and reducing criminal penalties associated with their use, highlighting a shift towards more progressive drug policies in New York.

Check Other States Licensing Guide

  • Adult Use
  • Medical
  • Limited Medical
  • Illegal

Where to Find Us


Address

Mr. Cannabis Law
1680 Michigan Ave.
Suite 700 #1042 
Miami Beach, FL 33139

Contact INFO

PHONE: 786-526-1155
EMAIL: info@mrcannabislaw.com

Rhode Island Cannabis License | Mr. Cannabis Law